4//SEC Filing
Iparraguirre John 4
Accession 0000914190-09-000192
CIK 0001140028other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 4:35 PM ET
Size
14.1 KB
Accession
0000914190-09-000192
Insider Transaction Report
Form 4
Iparraguirre John
Vice President & CFO
Transactions
- Award
Stock Option (right to buy)
2009-02-24+75,000→ 75,000 totalExercise: $0.14Exp: 2019-02-24→ Common Stock (75,000 underlying)
Holdings
- 15,926
Common Stock
- 100(indirect: By Spouse)
Common Stock
- 28,201
Stock Option (right to buy)
Exercise: $1.68Exp: 2014-05-09→ Common Stock (28,201 underlying) - 40,000
Stock Option (right to buy)
Exercise: $1.33Exp: 2015-04-11→ Common Stock (40,000 underlying) - 50,000
Stock Option (right to buy)
Exercise: $4.75Exp: 2015-11-10→ Common Stock (50,000 underlying) - 125,000
Stock Option (right to buy)
Exercise: $6.82Exp: 2016-12-12→ Common Stock (125,000 underlying) - 110,000
Stock Option (right to buy)
Exercise: $1.12Exp: 2017-12-14→ Common Stock (110,000 underlying)
Footnotes (4)
- [F1]Currently exercisable.
- [F2]41,666 shares vest on 12/12/07; 41,667 shares vest on each of 12/12/08 and 12/12/09.
- [F3]36,667 shares vest on each of 12/14/08 and 12/14/09; 36,666 shares vest on 12/14/10.
- [F4]25,000 shares vest on each of 2/24/10, 2/24/11 and 2/24/12.
Documents
Issuer
Hana Biosciences Inc
CIK 0001140028
Entity typeother
Related Parties
1- filerCIK 0001296552
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 4:35 PM ET
- Size
- 14.1 KB